Inventor · disambiguated record
Evan Styduhar
Also filed as: STYDUHAR EVAN
6 granted patents·3 pending applications·28 citations·filing 2019–2024
78Inventor score
Technology areasC07D
Files withINCYTE CORP9
Top patents by PatentIndex Score
9 records- 0195US11731958B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2020·Granted Aug 22, 2023·4 cites·25 claims
- 0295US10800761B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2019·Granted Oct 13, 2020·15 cites·12 claims
- 0392US11939331B2Tricyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2022·Granted Mar 26, 2024·4 cites·37 claims
- 0491US11897891B2Tricyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2020·Granted Feb 13, 2024·5 cites·41 claims
- 0577US12466815B2Carboxamide compounds and uses thereofINCYTE CORP·Filed 2023·Granted Nov 11, 2025·0 cites·66 claims
- 0666US2024317744A1Bicyclic Ureas As Kinase InhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 0761US2025353842A1Bicyclic amine cdk12 inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 0858US2023203010A1Bicyclic amine cdk12 inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 0957US12428420B2Tricyclic heterocycles as FGFR inhibitorsINCYTE CORP·Filed 2022·Granted Sep 30, 2025·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Evan Styduhar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →